Mednet is now part of the Launchit Ventures Group. Learn more >

Mednet Reports

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

PRIORITY PRESS - European Academy of Allergy and Clinical Immunology Congress

Current and Future SLIT Tablet Insights

Barcelona, Spain / June 6-10, 2015

Barcelona - Sublingual immunotherapy (SLIT) is working its way into allergy clinics with two oral tablets approved for use in patients with allergic rhinitis to grass pollen in Canada1. This type of therapy has been available in Europe...

PRIORITY PRESS - 13th Annual Primary Care Today

Primer on the Prevention of Invasive Meningococcal Disease: Perspectives from Pediatric Practices

Toronto, Ontario / May 6-9, 2015

Toronto - Invasive meningococcal disease (IMD) is a rare but catastrophic disease associated with high morbidity and mortality rates. Today by far and away the greatest proportion of IMD in Canada is caused by Neisseria meningitidis...

PRIORITY PRESS - 13th Annual Primary Care Today

Update on the 9-valent HPV Vaccine: Taking Prevention to a New Level

Toronto, Ontario / May 6-9, 2015

Toronto - A new 9-valent vaccine against the human papilloma virus (HPV) has recently been approved by Health Canada and is indicated for use in young girls and women between 9 and 45 years of age as well as in boys and men between 9 and 26...

PHYSICIAN PERSPECTIVE - Get With the Protocol - A Regional Perspective on the Evidence and Resulting Changes

St. Mary’s General Hospital

March 2015

Guest Editor: Hahn Hoe Kim, MD, FRCP(C) Department of CardiologySt. Mary’s General HospitalKitchener, Ontario   Introduction In patients presenting with an acute coronary syndrome (ACS), early initiation of oral antiplatelet...

PHYSICIAN PERSPECTIVE - Get With the Protocol - NSTEMI Decision-Tree Accelerates Introduction of Evidence-Based Therapies

University of Ottawa Heart Institute

February 2015

Guest Editor: Michel Le May, MD, FRCPCDirector, Coronary Care Unit, and University of Ottawa Heart Institute Regional STEMI ProgramProfessor of MedicineUniversity of Ottawa Heart InstituteOttawa, Ontario   Introduction In patients...

PRIORITY PRESS - American Heart Association (AHA) Scientific Sessions 2014

Lower Is Better: New Data Confirm the LDL Hypothesis as New Options Are Identified for Improved Control

Chicago, Illinois / November 15-19, 2014

Chicago - New evidence of a cardiovascular (CV) benefit from lipid-lowering therapy with a non-statin has extended the lipid hypothesis, expanding opportunities for risk reduction. One of the trials presented at the 2014 Scientific Sessions...

PRIORITY PRESS - 11th Canadian Immunization Conference

Influenza in the Elderly: Seeking More Effective Vaccine Strategies

Ottawa, Ontario / December 2-4, 2014

Ottawa - Elderly patients are at high risk for developing influenza and its complications, which can include increased frailty after hospitalization. Immunization in this population is vital, despite the fact that immune senescence lowers...

PRIORITY PRESS - 11th Canadian Immunization Conference

Expanding Protection against Influenza in the Most Vulnerable: Focus on Adjuvanted Influenza Vaccines

Ottawa, Ontario / December 2-4, 2014

Ottawa – The burden of illness associated with influenza infection is considerable, and it is particularly pronounced in the very young and in the elderly. Both groups respond less than optimally to standard influenza vaccines and...

PRIORITY PRESS - 11th Canadian Immunization Conference

Integrating the New Meningococcal B Vaccine into Clinical Practice: Lessons From the Experts

Ottawa, Ontario / December 2-4, 2014

Ottawa – Of the 5 serogroups responsible for invasive meningococcal disease (IMD), serogroup B is by far the most common in Canada today.  IMD also disproportionately affects young infants with another peak in incidence in...

PRIORITY PRESS - 56th Annual Meeting of the American Society of Hematology (ASH)

Selecting Second- and Third-Line TKIs in CML: Offering Tolerability in the Context of Indefinite Disease Control

San Francisco, California / December 6-9, 2014

San Francisco - A focus on the relative long-term safety and tolerability of available tyrosine kinase inhibitors (TKIs) for treatment of chronic myeloid leukemia (CML) has been intensified by the evidence that drugs in this class, when...

PAGE 5 OF 110   1 2 3 4 5 6 7 8 9 10 ...
All Rights Reserved - Mednet Inc.
Launchit Ventures
Mednet Inc. is part of the Launchit Ventures Group